Cancer therapy deal with Bristol-Myers Squibb boosts Five Prime drug

Five Prime Therapeutics Inc. snagged a deal with Bristol-Myers Squibb Co. around one of the leading drugs in the emerging class of cancer-fighting drugs known as immune checkpoint inhibitors...